InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Salmon Sean, Vice-Président Exécutif et Président, Diabète/Cardiovasculaire. Director active across 1 companies, notably Medtronic plc. Cumulatively, 8 filings have been recorded. The latest transaction was filed on 15 December 2021 — Retenue fiscale. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
€8,29489 shares@ €93.18670.0000% mcap0.8% of flow
Ordinary Shares
SEC:0001127602-21-031183·
€8,29489 shares@ €93.18670.0000% mcap0.4% of flow
Ordinary Shares
SEC:0001127602-21-031183:0·
€26,075245 shares@ €106.42690.0000% mcap2.7% of flow
Ordinary Shares
SEC:0001127602-21-028742·
€26,075245 shares@ €106.42690.0000% mcap1.3% of flow
Ordinary Shares
SEC:0001127602-21-028742:0·
€696,44021,129 shares@ €32.96130.0007% mcap70.9% of flow
Ordinary Shares
SEC:0001127602-21-024367·
€696,44021,129 shares@ €32.96130.0007% mcap35.5% of flow
Ordinary Shares
SEC:0001127602-21-024367:0·
€251,2382,272 shares@ €110.58010.0003% mcap25.6% of flow
Ordinary Shares
SEC:0001127602-21-023105·
€251,2382,272 shares@ €110.58010.0003% mcap12.8% of flow
Ordinary Shares
SEC:0001127602-21-023105:0·
8 of 8 declarations
About Salmon Sean
Sean Salmon is the Executive Vice President and President of the Diabetes/Cardiovascular division at Medtronic plc. He oversees operations and product development in this critical health sector. With a strong background in management and innovation, he strives to improve patient outcomes and expand access to healthcare. His leadership is essential to Medtronic's mission.
